当前位置:首页 - 行情中心 - 大禹生物(920970) - 财务分析 - 现金流量表

大禹生物

(920970)

  

流通市值:4.73亿  总市值:7.48亿
流通股本:7007.13万   总股本:1.11亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金81,047,924.0134,805,204.18180,988,932.16101,025,789.63
  收到的税费返还1,485.481,485.48--
  收到其他与经营活动有关的现金1,513,890.56538,243.217,219,315.6716,115,668.05
  经营活动现金流入小计82,563,300.0535,344,932.86198,208,247.83117,141,457.68
  购买商品、接受劳务支付的现金81,845,838.8942,965,024.74141,589,702.0294,516,476.7
  支付给职工以及为职工支付的现金16,081,523.468,702,606.9229,977,596.2422,775,209.11
  支付的各项税费3,282,410.14537,197.287,338,437.665,161,124.55
  支付其他与经营活动有关的现金4,170,819.661,758,209.99,121,147.578,360,998.32
  经营活动现金流出小计105,380,592.1553,963,038.84188,026,883.49130,813,808.68
  经营活动产生的现金流量净额-22,817,292.1-18,618,105.9810,181,364.34-13,672,351
二、投资活动产生的现金流量:
  收回投资收到的现金----8,020
  收到的其他与投资活动有关的现金---276,554.82
  投资活动现金流入的平衡项目---0
  投资活动现金流入小计---268,534.82
  购建固定资产、无形资产和其他长期资产支付的现金29,766,931.4617,328,927.7143,027,308.0329,199,023.93
  投资支付的现金383,747.74-8,216.72196.72
  支付其他与投资活动有关的现金---276,554.82
  投资活动现金流出小计30,150,679.217,328,927.7143,035,524.7529,475,775.47
  投资活动产生的现金流量净额-30,150,679.2-17,328,927.71-43,035,524.75-29,207,240.65
三、筹资活动产生的现金流量:
  取得借款收到的现金156,400,00050,400,000107,900,00092,900,000
  收到其他与筹资活动有关的现金15,000,000---
  筹资活动现金流入小计171,400,00050,400,000107,900,00092,900,000
  偿还债务支付的现金127,875,00014,475,00066,475,00050,875,000
  分配股利、利润或偿付利息支付的现金2,227,180.871,028,918.413,048,488.472,132,022.97
  支付其他与筹资活动有关的现金1,842,582.88211,242797,890.8587,890.8
  筹资活动现金流出小计131,944,763.7515,715,160.4170,321,379.2753,594,913.77
  筹资活动产生的现金流量净额39,455,236.2534,684,839.5937,578,620.7339,305,086.23
四、汇率变动对现金及现金等价物的影响-19,261.26-5,570.36-4,869.48-
五、现金及现金等价物净增加额-13,531,996.31-1,267,764.464,719,590.84-3,574,505.42
  加:期初现金及现金等价物余额30,394,424.5830,394,424.5825,674,833.7425,674,833.74
  期末现金及现金等价物余额16,862,428.2729,126,660.1230,394,424.5822,100,328.32
补充资料:
  净利润-26,549,609.3--29,853,181.08-
  资产减值准备15,832,943.01-2,540,919.07-
  固定资产和投资性房地产折旧14,126,275.68-27,767,014.25-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧14,126,275.68-27,767,014.25-
  无形资产摊销621,619.5-1,198,991.2-
  处置固定资产、无形资产和其他长期资产的损失-31,078.81---
  公允价值变动损失--2,360-
  财务费用2,504,352.83-3,442,927.7-
  投资损失253.34--22,743.28-
  递延所得税--0-
  存货的减少-41,440,059.91--19,051,843.88-
  经营性应收项目的减少-12,085,161.45-1,093,702.66-
  经营性应付项目的增加23,050,518.83-21,995,463.06-
  其他-84,420.92--78,487.93-
  现金的期末余额16,862,428.27-30,394,424.58-
  减:现金的期初余额30,394,424.58-25,674,833.74-
  现金及现金等价物的净增加额-13,531,996.31-4,719,590.84-
公告日期2026-08-242026-04-272026-04-272025-10-27
审计意见(境内)标准无保留意见
TOP↑